Understanding and Enhancing Health-Related Social Needs (HRSN) Screening Among Community Oncology Practices
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · May 10, 2024
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The primary objective of this study is to assess current processes around health related social needs (HRSN) screening among NCORP clinics and categorize clinics based on their implementation of HRSN screening. The primary endpoint will be a detailed understanding of current processes, with attention to variability by key clinic characteristics.
There are 3 parts of the study in which participants can participate in one or all parts (3 total).
Part 1: Participants attend training, complete clinic assessments and observations and may complete an interview on study.
Part 2: Identified clin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Part 1
- NCORP PRACTICES:
- • Must be an affiliate or sub-affiliate of an NCORP Community or Minority Underserved Community site
- • Must provide outpatient oncology care
- • Must be a NCORP practice (defined as one or more NCORP affiliates/sub-affiliates, that have a common administrative structure and share providers and/or patients)
- • Must have identified two or more Practice Staff that are available and willing to participate on the Practice Interest Form
- • Must have identified at least 1-3 outpatient oncology clinics willing to participate on the Practice Interest Form
- CLINICS:
- • 1-3 clinics within the practice should be selected
- • Clinics may or may not be located in different physical locations
- • The investigators will encourage NCORP practices to select clinics within a practice that differ in current or potential implementation of health related social needs (HRSN) screening (e.g., different clinic workflow or staff, different screening triggers, different tools), so that heterogeneity within NCORP practices can be captured
- • Clinics must be willing to allow Practice Staff participants to observe the clinical operations in-person
- PRACTICE STAFF:
- • Must be willing and able to take time to observe in person and document 1-3 selected clinics within the practice (approximately 2-3 hours per clinic)
- • Must be staff at the selected and enrolled practice. Suggestions of appropriate staff are cancer care delivery research (CCDR) Lead, research nurse, clinical research coordinator or NCORP Administrators. Staff members with primary clinical roles may also be appropriate, if available
- • Must be willing and able to participate in two 1.5 hour virtual training sessions
- • Must be willing to interview Clinic Key Informants (approximately 30 minutes per interview; in-person or remotely over the internet or by phone)
- • If the clinic is chosen for Part 2, must be willing to schedule an interview between Clinic Key Informant and Wake Forest health HRSN Study Team or designee
- • If the clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
- • Must be willing to be recorded when participating in interviews and the workshop.
- CLINIC KEY INFORMANT:
- • Must be willing to participate in Part 1 Operational Assessment, which involves a semi-structured interview (approximately 30 minutes; in-person or remotely over the internet or by phone) and a brief Non-patient Demographics Survey (approximately 5 minutes)
- • If the clinic is chosen for Part 2, must be willing to participate in an additional 45 minute interview (remotely over the internet or by phone)
- • If the clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
- • Part 3
- STAFF WORKSHOP PARTICIPANT:
- • Must be a clinic stakeholder (e.g., providers, practice managers, etc.) of the selected clinic
- • Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
- • Must be willing to be recorded when participating in interviews and the workshop.
- PATIENT WORKSHOP PARTICIPANT:
- • Must be a prospective clinic stakeholder (e.g., patient representative) of the selected clinic
- • Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
- • Must have received cancer treatment at the selected clinic within the last five years
- • Must be willing to be recorded when participating in the workshop.
- Exclusion Criteria:
- • Part 1
- PRACTICE STAFF:
- • \*\* Unable to understand, read and communicate in English, as the trainings and observations will be documented in English
- • Part 3
- STAFF WORKSHOP PARTICIPANT:
- • \*\* Unable to understand, read and communicate in English, as the workshop will be conducted in English
- PATIENT WORKSHOP PARTICIPANT:
- • \*\* Unable to understand, read and communicate in English, as the workshop will be conducted in English
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Flint, Michigan, United States
Des Moines, Iowa, United States
Urbana, Illinois, United States
Minneapolis, Minnesota, United States
Danville, Pennsylvania, United States
San Juan, , Puerto Rico
Milwaukee, Wisconsin, United States
Peoria, Illinois, United States
Brainerd, Minnesota, United States
Normal, Illinois, United States
New Orleans, Louisiana, United States
Elkton, Maryland, United States
Springfield, Missouri, United States
Pinehurst, North Carolina, United States
Fargo, North Dakota, United States
Appleton, Wisconsin, United States
Grafton, Wisconsin, United States
Bolivar, Missouri, United States
Greenville, South Carolina, United States
Greenville, South Carolina, United States
Kenosha, Wisconsin, United States
Newark, Delaware, United States
Flint, Michigan, United States
Effingham, Illinois, United States
Mattoon, Illinois, United States
Rockport, Maine, United States
Bayamon, , Puerto Rico
San Juan, , Puerto Rico
Tamuning, , Guam
Danville, Illinois, United States
Brunswick, Maine, United States
Ankeny, Iowa, United States
Des Moines, Iowa, United States
Winston Salem, North Carolina, United States
Flint, Michigan, United States
Duluth, Minnesota, United States
Patients applied
Trial Officials
Kathryn Weaver, PhD
Study Chair
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported